KERYX BIOPHARMACEUTICALS INC's ticker is KERX and the CUSIP is 492515101. A total of 132 filers reported holding KERYX BIOPHARMACEUTICALS INC in Q1 2016. The put-call ratio across all filers is 0.97 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $34,000 | -91.0% | 9,053 | -90.2% | 0.02% | -82.8% |
| Q1 2018 | $379,000 | +3.0% | 92,545 | +16.9% | 0.14% | +27.2% |
| Q4 2017 | $368,000 | -29.2% | 79,176 | +8.2% | 0.11% | -32.9% |
| Q3 2017 | $520,000 | +1.8% | 73,179 | +3.6% | 0.17% | -4.5% |
| Q2 2017 | $511,000 | +26.2% | 70,637 | +7.5% | 0.18% | +11.2% |
| Q1 2017 | $405,000 | +26.2% | 65,690 | +20.0% | 0.16% | +34.5% |
| Q4 2016 | $321,000 | +33.8% | 54,756 | +21.2% | 0.12% | +35.2% |
| Q3 2016 | $240,000 | -14.9% | 45,160 | +6.1% | 0.09% | -33.8% |
| Q2 2016 | $282,000 | +42.4% | 42,562 | +0.3% | 0.13% | +56.5% |
| Q1 2016 | $198,000 | +20.7% | 42,438 | +30.6% | 0.08% | 0.0% |
| Q4 2015 | $164,000 | +41.4% | 32,502 | -1.7% | 0.08% | +28.8% |
| Q3 2015 | $116,000 | +8.4% | 33,067 | +208.8% | 0.07% | +26.9% |
| Q2 2015 | $107,000 | -18.9% | 10,709 | +3.0% | 0.05% | -30.7% |
| Q1 2015 | $132,000 | – | 10,400 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VHCP Management, LLC | 700,273 | $10,770,000 | 5.76% |
| HARVEY CAPITAL MANAGEMENT INC | 932,400 | $14,340,000 | 5.13% |
| Camber Capital Management LP | 3,000,000 | $46,140,000 | 3.02% |
| Baupost Group | 10,539,986 | $162,105,000 | 2.64% |
| SECTORAL ASSET MANAGEMENT INC | 3,741,656 | $57,547,000 | 2.44% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3,884,409 | $59,742,000 | 2.40% |
| Knoll Capital Management, LLC | 200,000 | $3,076,000 | 1.37% |
| DAFNA Capital Management LLC | 92,400 | $1,421,000 | 1.35% |
| NORTHPOINTE CAPITAL LLC | 892,011 | $13,719,000 | 1.32% |
| Rhenman & Partners Asset Management AB | 240,000 | $3,691,000 | 1.10% |